Self-Reported Symptom and Adverse Event Profiles in Macrolide-Based Oral Treatment of Mycobacterium Avium Complex Pulmonary Disease

被引：0
|
作者：
Henkle, E. [1 ]
Philley, J. [2 ]
Addrizzo-Harris, D. J. [3 ]
Daley, C. L. [4 ]
Griffith, D. E. [5 ]
Aksamit, T. R. [6 ]
Swenson, C. [7 ]
Ruoss, S. J. [8 ]
Marras, T. K. [9 ,10 ]
Brunton, A. [11 ]
Winthrop, K. L. [11 ]
机构：
[1] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA
[2] Univ Texas Hlth Sci Ctr Tyler, Pulm CCM, Tyler, TX USA
[3] New York Univ, Med Ctr, New York, NY USA
[4] Natl Jewish Hlth, Mycobacterial Resp Infect, Denver, CO USA
[5] Natl Jewish Hlth, Denver, CO USA
[6] Mayo Clin, Rochester, MN USA
[7] Emory Univ, Pulm & Crit Care Med, Atlanta, GA 30322 USA
[8] Stanford Univ, Med, Stanford, CA 94305 USA
[9] Univ Toronto, Med, Toronto, ON, Canada
[10] Toronto Western Hosp, Toronto, ON, Canada
[11] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3882
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Kim, Hyung-Jun
    Lee, Jong Sik
    Kwak, Nakwon
    Cho, Jaeyoung
    Lee, Chang-Hoon
    Han, Sung Koo
    Yim, Jae-Joon
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [22] Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease
    Berning, SE
    Peloquin, CA
    CLINICAL INFECTIOUS DISEASES, 1996, 22 (05) : 885 - 885
  • [23] Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease
    Ito, Masashi
    Koga, Yasuhiko
    Hachisu, Yoshimasa
    Murata, Keisuke
    Sunaga, Noriaki
    Maeno, Toshitaka
    Hisada, Takeshi
    RESPIRATORY INVESTIGATION, 2022, 60 (05) : 613 - 624
  • [24] Mycobacterium avium Complex Pulmonary Disease: Characteristics and Treatment in an Irish Patient Cohort
    Judge, E. P.
    Ahmed, M.
    Fitzgibbon, M.
    McLaughlin, A. M.
    Keane, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S522 - S522
  • [25] BACES SCORE AND TREATMENT OUTCOMES IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE
    Vadiyala, Mounika Reddy
    Conley, Elyse
    Arias-Sanchez, Pedro
    Karnakoti, Snigdha
    Marty, Paige
    Pathakumari, Balaji
    VanKeulen, Virginia
    Peikert, Tobias
    Ju, Nianqiao Phyllis
    Pienaar, Elsje
    Pennington, Kelly
    Escalante, Patricio
    CHEST, 2023, 164 (04) : 887A - 888A
  • [26] Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease
    Kim, Joong-Yub
    Bae, Juye
    Hyung, Kwonhyung
    Lee, Inhan
    Park, Hyun-Jun
    Kim, So Yeon
    Lee, Kyung-Eui
    Ahn, Yoon Hae
    Yoon, Si Mong
    Kwak, Nakwon
    Yim, Jae-Joon
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Tolerability and efficacy of Mycobacterium avium complex pulmonary disease treatment in elderly patients
    Shinfuku, Kyota
    Hara, Hiromichi
    Okuda, Keitaro
    Miyagawa, Hanae
    Takasaka, Naoki
    Ishikawa, Takeo
    Araya, Jun
    BMC PULMONARY MEDICINE, 2025, 25 (01):
  • [28] TREATMENT AND OUTCOMES OF MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE IN AUCKLAND, NEW ZEALAND
    Chen, C.
    Davies, R.
    Lewis, C.
    Harrison, A.
    Paynter, J.
    Nisbet, M.
    RESPIROLOGY, 2021, 26 : 199 - 199
  • [29] Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease
    Moon, Seong Mi
    Yoo, In Young
    Huh, Hee Jae
    Lee, Nam Yong
    Jhun, Byung Woo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
  • [30] Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease
    Kim, Joong-Yub
    Kim, Na Young
    Jung, Hee-Won
    Yim, Jae-Joon
    Kwak, Nakwon
    BMC PULMONARY MEDICINE, 2022, 22 (01)
12345